¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"aging patient"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® aging, senescence ÇÑ±Û ³ëÈ­, ´ÄÀ½
¼³¸í   
  ³ªÀÌ ¸Ô´Â´Ù´Â Àǹ̷Π»ç¿ëµÇ±âµµ ÇÏÁö¸¸ ÀϹÝÀûÀ¸·Î´Â ¼ºÀåÀÌ ¿Ï·á, Á¤ÁöµÇ°í ±× ÀÌÈÄ¿¡ ÀϾ´Â ¸ðµç °úÁ¤À» °¡¸®Å²´Ù. ³ªÀ̸¦ ¸Ô¾î°¨¿¡ µû¶ó »ýüÀÇ ¿©·¯ °¡Áö ±â´ÉÀÌ ÀúÇϵǴµ¥, ÀϹÝÀûÀ¸·Î ¼¼Æ÷¿¡ »ö¼Ò°¡ ÃàÀûµÇ°Å³ª ¼¼Æ÷ÀÚü³ª ÇÙÀÌ ÀÛ¾ÆÁö´Â Çö»óÀÌ´Ù. °³°³ÀÇ ¼¼Æ÷ ±â´Éµµ ÀúÇϵǰí, ¼¼Æ÷ ³»¿¡ »ö¼Ò°¡ Ä§ÂøµÇ¸ç, ±â°üÀº ¾Ï°¥»öÀ» ¶í´Ù. ¶ÇÇÑ ÇǺδ ¾ã¾ÆÁö°í ÅÐÁָӴϵµ À§ÃàµÇ¸ç, ¸ð¹ßÀº »ö¼Ò¸¦ ÀÒ°í Å»¸ðµÈ´Ù. ÇöÀç ¸¹Àº ÇÐÀÚµéÀº ¼¼Æ÷³» DNA°¡ ²÷¾îÁö°Å³ª ²÷¾îÁø °æ¿ì ¼öº¹·ÂÀÌ °¨¼ÒÇϰųª, ¸é¿ª·ÂÀÌ ÀúÇÏÇϱ⠶§¹®À¸·Î º¸°í ÀÖ´Ù. ³ëÈ­°¡ ÀϾ´Â °ÍÀº ¼¼Æ÷ÀÇ Á¾·ù¿¡ µû¶ó¼­ Å©°Ô ´Ù¸¥µ¥ ½Å°æ¼¼Æ÷󷳠ž¼­ Á×À» ¶§±îÁö ¼¼Æ÷ºÐ¿­ÇÏÁö ¾Ê´Â ¼¼Æ÷´Â ³ëÈ­°¡ µÎµå·¯Áö°í °íȯÀ̳ª °ñ¼öÀÇ ¼¼Æ÷ó·³ Ç×»ó ºÐ¿­Çϴ ¼¼Æ÷´Â ³ëÈ­Çö»óÀÌ °ÅÀÇ ÀϾÁö ¾Ê´Â´Ù. ¹ßº´°ú Á×À½ÀÇ È®·üÀÌ ³ô¾ÆÁöÁö¸¸, ³ë¼è¼º º¯È­¿Í º´Àû º¯È­¿ÍÀÇ °æÁ¦´Â ¸íÈ®ÇÏÁö ¾Ê´Ù. ³ë¼è¸¦ ¾ß±âÇϴ ³ëÈ­ÀÇ º»ÁúÀû ¿øÀο¡ ´ëÇØ¼­´Â ¾ÆÁ÷ Á¤¼³ÀÌ ¾ø´Ù.
¿µ¹® doctor-patient relationship ÇÑ±Û ÀÇ»çȯÀÚ°ü°è
¼³¸í   
  »çȸÀûÀ¸·Î ±â´ëµÇ´Â °¢ ¿ªÇÒ¿¡ µû¸¥ »óÈ£ÇàÀ§¸¦ ÅëÇØ¼­ ÀÇ»ç¿Í È¯ÀÚ°¡ ¸Î´Â °ü°è. ÀÇ»ç-ȯÀÚ°ü°è´Â, ¨ç ´Éµ¿Àû-¼öµ¿Àû°ü°è, ¨è Áöµµ-Çù·Â°ü°è, ¨é »óÈ£Âü°¡°ü°èÀÇ ¼¼ °¡Áö·Î À¯ÇüÈ­ÇÒ ¼ö ÀÖ´Ù. Áúº´±¸Á¶ÀÇ Áß½ÉÀÌ ±Þ¼º Áúȯ¿¡¼­ ¸¸¼ºÁúȯÀ¸·Î ÀÌÇàÇϴ °¡¿îµ¥ ÀÇ»ç-ȯÀÚ°ü°èµµ ¨ç¿¡¼­ ¨éÀ¸·Î ¹Ù²î´Â °ÍÀÌ ¿ä±¸µÇ°í ÀÖ´Ù. ±×·¯³ª ÀϹæÀûÀ¸·Î ÀÏÇϴ ÀÇ»ç¿Í Áö½Ã¿¡ µû¸£±â¸¸ Çϴ ¼öµ¿Àû È¯ÀÚ¿ÍÀÇ °ü°è´Â ¾ÆÁ÷µµ »Ñ¸®±í°Ô ³²¾ÆÀÖ´Ù. ¶Ç ÃÖ±ÙÀÇ ÀÇ·á±â°èÈ­´Â ÀÇ»ç¿Í È¯ÀÚ°¡ ±â°è¸¦ ¸Å°³·Î Çؼ­ °£Á¢ÀûÀ¸·Î »óÈ£¿¬°üµÇ´Â »õ·Î¿î °ü°è±îÁöµµ ³º°í ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    1. ³ëÈ­ 2. ³ë·ÉÈ­ 3. ³ªÀ̸ÔÀ½
  • aging process
    ³ëÈ­°úÁ¤
  • cellular aging
    ¼¼Æ÷³ëÈ­
  • programmed aging
    ¿¹Á¤³ëÈ­
  • critically ill patient
    ÁßȯÀÚ
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è
  • high risk patient
    °íÀ§ÇèȯÀÚ
  • litter patient
    µé°ÍȯÀÚ
  • patient
    ȯÀÚ
  • patient identification
    ȯÀÚÈ®ÀÎ
  • patient positioning
    ȯÀÚÀ§Ä¡°áÁ¤
  • patient triggered respirator
    ȯÀÚÀ¯¹ß½ÄÈ£Èí±â
  • patient triggered ventilator
    ȯÀÚÀ¯¹ß½Äȯ±â±â
  • patient-controlled analgesia
    ÀÚ°¡Á¶ÀýÁøÅë
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    ³ëÈ­, ³ªÀ̸ÔÀ½
  • aging process
    ³ëÈ­°úÁ¤
  • patient
    ȯÀÚ
  • critically ill patient
    ÁßȯÀÚ
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    ³ëÈ­, ´ÄÀ½
  • aging process
    ³ëÈ­°úÁ¤
  • cellular aging
    ¼¼Æ÷³ëÈ­
  • programmed aging
    ¿¹Á¤³ëÈ­
  • patient-controlled analgesia
    ÀÚ°¡Á¶ÀýÁøÅë
  • critically ill patient
    ÁßȯÀÚ
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è
  • patient identification
    ȯÀÚÈ®ÀÎ
  • litter patient
    µé°ÍȯÀÚ
  • patient
    ȯÀÚ
  • patient positioning
    ȯÀÚÀ§Ä¡°áÁ¤
  • patient triggered respirator
    ȯÀÚÀ¯¹ß½ÄÀΰøÈ£Èí±â
  • patient triggered ventilator
    ȯÀÚÀ¯¹ßÈ£Èí±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging,free radical theory
    À¯¸®±â ¼³(ë´×îÐñàã)
  • programmed aging
    °èȹµÈ¡¡³ëÈ­
  • admitted patient
    ÀÔ¿øÈ¯ÀÚ.
  • geriatric patient
    ³ëÀÎȯÀÚ
  • professional patient
    Àü¹®°¡ ȯÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging patient
    °í·ÉȯÀÚ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    ³ëÈ­(ÒÇûù)
  • aging
    ³ëÈ­(ÖÕûù)
  • aging
    ³ëÈ­(ËÈÌ´), °¡·É(˧ËÈ).
  • aging
    ³ëÈ­, °¡·É(Ê¥ÖÆ)
  • aging test
    ³ëÈ­½ÃÇè(ËÈÌ´ËàÌ´).
  • aging,free radical theory
    À¯¸®±â ¼³(ë´×îÐñàã)
  • cellular aging
    ¼¼Æ÷³ëÈ­(á¬øàÖÕûù)
  • myocardium,aging effect
    ³ëÈ­Çö»ó(ÖÕûùúÞßÚ)
  • programmed aging
    °èȹµÈ¡¡³ëÈ­
  • admitted patient
    ÀÔ¿øÈ¯ÀÚ.
  • complaints of patient
    ȯÀÚÀÇ È£¼Ò(ü´íº¡­û¼áÍ).
  • convalescent =patient
    ȸº¹±âÀÇ, ȸº¹±âȯÀÚ(¡­ü´íº).
  • doctor-patient relationship
    ÀÇ»çȯÀÚ(½Å·Ú)°ü°è(ì¢ÞÔü´íºãá μÌõ).
  • doctor-patient relationship
    ÀÇ»çȯÀÚ(½Å·Ú)°ü°è(ËöË×Ì·ËöËà Ë´Ë­).
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è(ì¢ÞÔü´íºãá μÌõ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    ³ëÈ­(ÒÇûù)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    ³ëÈ­, °¡·É
  • ambulatory patient
    ¿Ü·¡È¯ÀÚ, º¸Çà°¡´ÉȯÀÚ
  • patient
    ȯÀÚ
  • patient position
    ȯÀÚÀÇ ÀÚ¼¼
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PCA para-chloramphetamine; parietal cell antibody; passive cutaneous anaphylaxis; patient care assistant...
AAA abdominal aortic aneurysm/aneurysmectomy; acne-associated arthritis; acquired aplastic anemia; acute...
AAHA American Academy of Hospital Attorneys; American Association of Homes for the Aging
ABS abdominal surgery; acute brain syndrome; Adaptive Behavior Scale; admitting blood sugar; adult bovin...
AFAR American Foundation for Aging Research
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BLSA Baltimore Longitudinal Study of Aging
CSHA Canadian Study of Health and Aging
LSOA Longitudinal Study of Aging
NIA National Institute of Aging
APG Ambulatory Patient Groups
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • aging patient
    °í·É ȯÀÚ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • aging
    ³ëÈ­, °¡·É, ½Ãȿó¸®
    1. Áúº´ ¶Ç´Â ±âŸÀÇ Å« »ç°í µî¿¡ ÀÇÇÑ °ÍÀÌ ¾Æ´Ï¸ç ½Ã°£°æ°ú, Áï ¿¬·É Áõ°¡¿¡ µû¶ó ¼ö¹ÝµÇ´Â »ýü ±¸Á¶ÀÇ ¿Ï¸¸ÇÑ º¯È­·Î¼­ ±Ã±ØÀûÀ¸·Î´Â ¿¬·ÉÀÌ ¸¹¾ÆÁ®, Áï ´Ä¾î¼­ »ç¸Á¿¡ À̸¥´Ù. 2. °¡°ø º¯Çü ¹× ÁÖÁ¶ Æí¼®À» ¾ø¾Ö±â À§ÇÑ ¼ÒµÐ°ú ±â°èÀû ¼ºÁúÀ» ¹Ù²Ù´Â °Í.
  • aging phenomena
    ³ë¼è Çö»ó
  • aging,free radical theory
    À¯¸®±â¼³
  • myocardium,aging effect
    ³ëÈ­ Çö»ó
  • adipose patient
    Áö¹æ¼º ȯÀÚ
  • between-patient variability
    ȯÀÚ°£ º¯È­
  • doctor-patient relationship
    ÀÇ»ç-ȯÀÚ °ü°è, ÀÇ»ç ȯÀÚ ½Å·Ú °ü°è
  • dying patient
    ÀÓÁ¾ ȯÀÚ
  • elderly patient
    ³ëÀΠȯÀÚ
  • first-time dental patient
    óÀ½ ³»¿øÇÑ È¯ÀÚ
  • in-patient general anesthesia
    ÀÔ¿ø Àü½Å ¸¶Ãë
  • neurotic patient
    ½Å°æÁõ ȯÀÚ
  • non-patient
    ºñȯÀÚ
  • out-patient general anesthesia
    ¿Ü·¡ Àü½Å ¸¶Ãë
  • patient
    ȯÀÚ
    1. ÀÇÇÐÀû Ä¡·á¸¦ ¹Þ°í ÀÖ´Â »ç¶÷, ƯÈ÷ º´¿ø¿¡¼­. 2. ÀÇ»ç, Ä¡°ú ÀÇ»ç µî¿¡ µî·ÏµÇ¾î Çʿ信 µû¶ó ±×¿¡°Ô Ä¡·á¸¦ ¹Þ´Â »ç¶÷.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
aging The gradual changes in the structure and function of humans and animals that occur with the passage of time, that do not result from disease or other gross accidents, and that eventually lead to the increased probability of death as the person or animal grows older. It does not apply to microorganisms.
(12 Dec 1998)
aging, premature Changes in the organism associated with senescence, occurring at an accelerated rate.
(12 Dec 1998)
cell aging The decrease in the cell's ability to proliferate with the passing of time. Each cell is programmed for a certain number of cell divisions and at the end of that time proliferation halts. The cell enters a quiescent state after which it experiences cell death via the process of apoptosis.
(12 Dec 1998)
clonal aging The deterioration in successive generations of a clone; thus paramecia and other simple forms, if allowed to reproduce asexually for a number of generations, invariably undergo deterioration, the characters of each group of descendants progressively departing from those of the original sexually produced ancestor.
(05 Mar 2000)
skin aging The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight.
(12 Dec 1998)
erythrocyte aging Senescence of the red blood cell. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days.
(12 Dec 1998)
analgesia, patient-controlled Relief of pain, without loss of consciousness, through an analgesic agent administered by the patient. It has been used successfully to control postoperative pain, during labour, after burns, and in terminal care. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimised by combining small bolus doses with a mandatory interval between successive doses (lockout interval).
(12 Dec 1998)
patient 1. A person who is receiving medical treatment, especially in a hospital.
2. A person who is registered with a doctor, dentist, etc and is treated by him when necessary.
(18 Nov 1997)
patient acceptance of health care The seeking and acceptance by patients of health service.
(12 Dec 1998)
patient admission The process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution.
(12 Dec 1998)
patient advocacy Promotion and protection of the rights of patients, frequently through a legal process.
(12 Dec 1998)
patient care The services rendered by members of the health profession and non-professionals under their supervision for the benefit of the patient.
(12 Dec 1998)
patient care management Generating, planning, organizing, and administering medical and nursing care and services for patients.
(12 Dec 1998)
patient care planning Usually a written medical and nursing care program designed for a particular patient.
(12 Dec 1998)
patient care team Care of patients by a multidisciplinary team usually organised under the leadership of a physician; each member of the team has specific responsibilities and the whole team contributes to the care of the patient.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    ³ªÀ̸¦ ¸ÔÀ½
  • patient
    Àγ»½ÉÀÌ °­ÇÑ,ȯÀÚ
  • mental patient
    Á¤½Åº´ ȯÀÚ
  • patient
    Àγ»·ÂÀÌ °­ÇÑ;±Ù¸éÇÑ
  • patient compliance
    ȯÀÚÀÇ ¼ö¿ë»óÅÂ;ÀÀ³« »óÅÂ
  • private patient
    (ÀÇ·á º¸ÇèÀÇ) °³ÀÎ ºÎ´ã ȯÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á